Literature DB >> 2115096

The CE plane: a graphic representation of cost-effectiveness.

W C Black1.   

Abstract

The concept of cost-effectiveness is illustrated graphically on the CE plane. Strategies are represented according to their effectiveness (e) and cost (c) relative to those of some reference standard. A straight line with slope K passes through the origin, where K is the maximum acceptable cost-effectiveness ratio. Strategies plotted to the right of line K are cost-effective, while those plotted to the left are not. Furthermore, the most cost-effective of two or more mutually exclusive alternatives is that plotted the greatest distance to the right of K. The CE plane can be used to resolve ambiguities about the meaning of cost-effectiveness and to illustrate its relevance to medical decision making.

Mesh:

Year:  1990        PMID: 2115096     DOI: 10.1177/0272989X9001000308

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  131 in total

Review 1.  Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

Authors:  A O'Hagan; J W Stevens; J Montmartin
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

2.  Summarising economic evaluations in systematic reviews: a new approach.

Authors:  J Nixon; K S Khan; J Kleijnen
Journal:  BMJ       Date:  2001-06-30

Review 3.  Pharmacoeconomics and pharmacoepidemiology: curious bedfellows or a match made in heaven?

Authors:  Andrew H Briggs; Adrian R Levy
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 4.  Economic Evidence and Point-of-Care Testing.

Authors:  Andrew St John; Christopher P Price
Journal:  Clin Biochem Rev       Date:  2013-08

5.  Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.

Authors:  Arri Coomarasamy; Hoda M Harb; Adam J Devall; Versha Cheed; Tracy E Roberts; Ilias Goranitis; Chidubem B Ogwulu; Helen M Williams; Ioannis D Gallos; Abey Eapen; Jane P Daniels; Amna Ahmed; Ruth Bender-Atik; Kalsang Bhatia; Cecilia Bottomley; Jane Brewin; Meenakshi Choudhary; Fiona Crosfill; Shilpa Deb; W Colin Duncan; Andrew Ewer; Kim Hinshaw; Thomas Holland; Feras Izzat; Jemma Johns; Mary-Ann Lumsden; Padma Manda; Jane E Norman; Natalie Nunes; Caroline E Overton; Kathiuska Kriedt; Siobhan Quenby; Sandhya Rao; Jackie Ross; Anupama Shahid; Martyn Underwood; Nirmala Vaithilingham; Linda Watkins; Catherine Wykes; Andrew W Horne; Davor Jurkovic; Lee J Middleton
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

6.  Costs and effects in lumbar spinal fusion. A follow-up study in 136 consecutive patients with chronic low back pain.

Authors:  Rikke Soegaard; Finn Bjarke Christensen; Terkel Christiansen; Cody Bünger
Journal:  Eur Spine J       Date:  2006-07-27       Impact factor: 3.134

7.  Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial.

Authors:  Aureliano Paolo Finch; Patricia van Velzen; Gerben Ter Riet; Peter J Sterk; Jan M Prins; Judith E Bosmans
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

8.  Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer.

Authors:  Silas C Martin; Dennis D Gagnon; Lucy Zhang; Carsten Bokemeyer; Marinus Van Marwijk Kooy; Ben van Hout
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis.

Authors:  Nicolas Penel; Yazdan Yazdanpanah
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

10.  Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).

Authors:  Nadja Chernyak; Frank Petrak; Kristin Plack; Martin Hautzinger; Matthias J Müller; Guido Giani; Andrea Icks
Journal:  BMC Geriatr       Date:  2009-07-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.